» Articles » PMID: 25360382

Estimate of Tissue Composition in Malignant and Benign Breast Lesions by Time-domain Optical Mammography

Overview
Specialty Radiology
Date 2014 Nov 1
PMID 25360382
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The optical characterization of malignant and benign breast lesions is presented. Time-resolved transmittance measurements were performed in the 630-1060 nm range by means of a 7-wavelength optical mammograph, providing both imaging and spectroscopy information. A total of 62 lesions were analyzed, including 33 malignant and 29 benign lesions. The characterization of breast lesions was performed applying a perturbation model based on the high-order calculation of the pathlength of photons inside the lesion, which led to the assessment of oxy- and deoxy-hemoglobin, lipids, water and collagen concentrations. Significant variations between tumor and healthy tissue were observed in terms of both absorption properties and constituents concentration. In particular, benign lesions and tumors show a statistically significant discrimination in terms of absorption at several wavelengths and also in terms of oxy-hemoglobin and collagen content.

Citing Articles

Diffuse correlation tomography: a technique to characterize tissue blood flow abnormalities in benign and malignant breast lesions.

Zhang R, Lu J, Di W, Gui Z, Chan S, Yang F Biomed Opt Express. 2024; 15(11):6259-6276.

PMID: 39553863 PMC: 11563337. DOI: 10.1364/BOE.535330.


Monitoring of neoadjuvant chemotherapy through time domain diffuse optics: breast tissue composition changes and collagen discriminative potential.

Mule N, Maffeis G, Cubeddu R, Santangelo C, Bianchini G, Panizza P Biomed Opt Express. 2024; 15(8):4842-4858.

PMID: 39346975 PMC: 11427201. DOI: 10.1364/BOE.527968.


Investigating the feasibility of a hand-held photoacoustic imaging probe for margin assessment during breast conserving surgery.

Rascevska E, Yip L, Omidi P, Brackstone M, Carson J Photoacoustics. 2022; 28:100424.

PMID: 36386296 PMC: 9650058. DOI: 10.1016/j.pacs.2022.100424.


Anthropomorphic Polydimethylsiloxane silicone-based phantom for Diffuse Optical Imaging.

Waks Serra M, Noseda Grau V, Vera D, Jodra S, Garcia H, Carbone N Heliyon. 2022; 8(8):e10308.

PMID: 36033332 PMC: 9404336. DOI: 10.1016/j.heliyon.2022.e10308.


Evaluation of a pipeline for simulation, reconstruction, and classification in ultrasound-aided diffuse optical tomography of breast tumors.

Di Sciacca G, Maffeis G, Farina A, Dalla Mora A, Pifferi A, Taroni P J Biomed Opt. 2022; 27(3).

PMID: 35332743 PMC: 8943242. DOI: 10.1117/1.JBO.27.3.036003.


References
1.
Marshall E . Public health. Brawling over mammography. Science. 2010; 327(5968):936-8. DOI: 10.1126/science.327.5968.936. View

2.
Grosenick D, Moesta K, Wabnitz H, Mucke J, Stroszczynski C, Macdonald R . Time-domain optical mammography: initial clinical results on detection and characterization of breast tumors. Appl Opt. 2003; 42(16):3170-86. DOI: 10.1364/ao.42.003170. View

3.
Grosenick D, Wabnitz H, Rinneberg H, Moesta K, Schlag P . Development of a time-domain optical mammograph and first in vivo applications. Appl Opt. 2008; 38(13):2927-43. DOI: 10.1364/ao.38.002927. View

4.
van de Ven S, Elias S, Wiethoff A, van der Voort M, Leproux A, Nielsen T . Diffuse optical tomography of the breast: initial validation in benign cysts. Mol Imaging Biol. 2008; 11(2):64-70. PMC: 2696611. DOI: 10.1007/s11307-008-0176-x. View

5.
Lochter A, Bissell M . Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol. 1995; 6(3):165-73. DOI: 10.1006/scbi.1995.0017. View